Blog November 9, 2023 Legal Alert: FTC Challenges More Than 100 Patents as Improperly Listed in Orange Book Read more
Blog November 3, 2023 District of Delaware Finds Allergan Patents Invalid for Lack of Written Description and Obviousness-Type Double Patenting in Allergan v. MSN Labs Read more
Blog October 30, 2023 District of Delaware Finds Non-Orange Book-Listed Patents Subject to the Same Pleading Standard as Listed Patents in ANDA Infringement Suit Read more
Blog September 25, 2023 Federal Circuit Evaluates Enablement for Antibody Claims for the First Time Since Amgen v. Sanofi in Baxalta Inc. et al. v. Genentech, Inc. Read more